Neurent Medical raises €22.5M Series B round
20 January 2021· Galway, Ireland· health, medtech, medical_devices, b2b, software_hardware
The financing will support the expansion of the company's clinical and commercial operations as it prepares for U.S. Food and Drug Administration (FDA) clearance and U.S. commercialization of its proprietary NEUROMARK™ Rhinitis Neurolysis Therapy™.
Investors
LeadLSP
Also participating
Atlantic BridgeFountain Healthcare Partners
About Neurent Medical
Stage
Series C
Headquarters
Galway, Ireland
Founded
2015
Team Size
21–50
Sectors
healthmedtechmedical_devicesb2bsoftware_hardware